NCT01162915View on ClinicalTrials.gov

Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury

PHASE1SuspendedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Spinal Cord Injury
Interventions
BIOLOGICAL

Autologous bone marrow-derived mesenchymal stem cells.

Intrathecal infusion of a single dose of ex vivo expanded MSC.

Trial Locations (1)

70433

TCA Cellular Therapy, LLC, Covington

Sponsors
All Listed Sponsors
lead

TCA Cellular Therapy

INDUSTRY